Related Experiment Videos
The immunological crossreaction between human alpha-fetoprotein and serum albumin and its relation with the binding
Chemical & Pharmaceutical Bulletin
|December 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Isomerization of ceftibuten in aqueous solution.
Journal of pharmaceutical sciences·1998
Free forearm flap reconstruction of the posterior tracheal wall invaded by esophageal carcinoma.
Journal of reconstructive microsurgery·1998
Mechanism of endothelium-dependent relaxation induced by thrombin in the pig coronary artery.
European journal of pharmacology·1998
The recovering effect of betaine on carbon tetrachloride-induced liver injury.
Journal of nutritional science and vitaminology·1998
Granulated Ammonium Alginate as a Functional Sodium-Sequestration Agent: Formulation Optimization Using Box-Behnken Design.
Chemical & pharmaceutical bulletin·2026
Quinoline-Dependent Electronic Response and Acyl Group Control of Linker Cleavage in a Folded Nitrene Precursor.
Chemical & pharmaceutical bulletin·2026
Preparation of Highly Functionalized ortho-Naphthoquinone Methides and Their Subsequent Intermolecular [4 + 2]-Cycloadditions with Olefins.
Chemical & pharmaceutical bulletin·2026
Mechanistic Elucidation of the Acidic Hydrolysis of Triazolobenzodiazepines: Integration of Kinetic, Thermodynamic, and Quantum Chemical Analyses.
Chemical & pharmaceutical bulletin·2026
Detection of Crystalline Ibuprofen Components in Ibuprofen-Loaded SBA-15 Mesoporous Silica Using Time-Domain NMR.
Chemical & pharmaceutical bulletin·2026
Evaluation of Water-Related T2 Relaxation Behavior in Hot-Melt Extruded Clotrimazole/PVPVA Solid Dispersions Using Time-Domain NMR.
Chemical & pharmaceutical bulletin·2026
Primary Burkitt Lymphoma of the Maxillary Sinus in an Immunocompetent Adult: A Case Report.
Turkish archives of otorhinolaryngology·2026
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab.
Pediatric blood & cancer·2026